Stocks and Investing
Stocks and Investing
Thu, March 16, 2017
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 04:45 AM ] - WOPRAI
[ 04:45 AM ] - WOPRAI
[ 04:45 AM ] - WOPRAI
[ 04:45 AM ] - WOPRAI
[ 01:46 AM ] - WOPRAI
[ 01:45 AM ] - WOPRAI
[ 01:45 AM ] - WOPRAI
[ 01:45 AM ] - WOPRAI
[ 01:45 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Edward White Initiated (SNDX) at Buy and Held Target at $27 on, Mar 16th, 2017
Edward White of FBR Capital, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Buy and Held Target at $27 on, Mar 16th, 2017.
Edward has made no other calls on SNDX in the last 4 months.
There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Christopher Marai of "Nomura" Initiated at Strong Buy on, Thursday, March 2nd, 2017